BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2471546)

  • 1. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
    MacKie RM; White SI; Seywright MM; Young H
    Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
    Rose DS
    J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS; Gilham P
    Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study.
    Crocker J; Skilbeck N
    J Clin Pathol; 1987 Aug; 40(8):885-9. PubMed ID: 3654987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
    Fallowfield ME; Cook MG
    Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in melanocytic dysplasia and melanoma.
    Fallowfield ME; Dodson AR; Cook MG
    Histopathology; 1988 Jul; 13(1):95-9. PubMed ID: 3209193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The approach to the patient with a difficult melanocytic lesion.
    Elder DE; Xu X
    Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear and cytoplasmic features in the diagnosis of banal nevi, Spitz nevi, and melanoma.
    Valdebran M; Elbendary A; Chaitanya Arudra SK; Torres KM; Elattar I; Elston DM
    J Am Acad Dermatol; 2016 Nov; 75(5):1032-1037.e8. PubMed ID: 27542585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.
    Mackie RM; Campbell I; Turbitt ML
    J Clin Pathol; 1984 Apr; 37(4):367-72. PubMed ID: 6200506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
    Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
    Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural study of superficial spreading melanoma and benign simulants.
    Mintzis MM; Silvers DN
    Cancer; 1978 Aug; 42(2):502-11. PubMed ID: 679152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.